<DOC>
	<DOC>NCT00976235</DOC>
	<brief_summary>This is a 5-year study of patients implanted with the Implantable Miniature Telescope (IMT by Dr. Isaac Lipshitz) under Protocol IMT-002. All patients implanted with the telescope prosthesis who enrolled in the IMT-002 trial were asked to participate in this study to monitor long-term safety. Patients will undergo examinations at six-month intervals up to a total of 5 years following implantation.</brief_summary>
	<brief_title>A Long-Term Monitoring Study of the IMT-002 Patients</brief_title>
	<detailed_description>Every 6 months, manifest refraction, visual acuity, intraocular pressure, slit lamp examination, endothelial cell density, device failures, complications and adverse events will be assessed.</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Patients must have participated in the IMT002 trial. Patients must be able to understand and comply with the requirements of the clinical study, and be able to abide by the requirements and restrictions of the study. Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form. Patients who have not participated in the IMT002 trial.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Macular Degeneration</keyword>
	<keyword>Visual Impairment</keyword>
	<keyword>Quality of Life</keyword>
	<keyword>Telescope Prosthesis</keyword>
</DOC>